The basal-like subtype is defined through gene expression microarray analysis; nevertheless, the term triple-negative belongs to the immunohistochemical classification of breast cancers lacking HER2, PR, and ER protein expression [6,7]. Here, ERBB2 is linked to breast carcinoma.